A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers.
from Top Health News -- ScienceDaily https://ift.tt/2LSf5jb
No comments:
Post a Comment